Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. australasia
  4. approved drug
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • Australasia
  • American Samoa
  • Australia
  • Fiji
  • Kiribati
  • Marshall Islands
  • Micronesia
  • New Zealand
  • Palau
  • Papua New Guinea
  • Solomon Islands
  • Tonga
  • Tuvalu
  • Vanuatu
Brands

  • adalta

Approved Drug Equipment Supplied In Australasia

3 equipment items found
In AustralasiaAvailable In AustralasiaNear Australasia

Nerve Cells Therapeutic

Nerve Cells Therapeutic

Manufactured by:NeuroScientific Biopharmaceuticals Ltd.   based inCottesloe, AUSTRALIA
“Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt neurodegeneration. We believe that EmtinB has potential to bridge this gap and bring this breakthrough medicine to clinics, bringing new hope to patients and ...
CONTACT SUPPLIER

Targeted Antibody Therapy

Targeted Antibody Therapy

Manufactured by:Biosceptre International Limited   based inCambridge, UNITED KINGDOM
We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular nature of the antibody structure, the same panel of antibody sequences can be used to generate a variety of therapeutic antibody formats including, but not limited to, ...
CONTACT SUPPLIER

AdAlta - i-body Technology Platform

AdAlta - i-body Technology Platform

by:AdAlta Limited   based inBundoora, AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT